Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 17.42M $1.22B Dec. 31, 2013
Sands Capital Management 9.74M $664.21M March 31, 2014
Jennison Associates 8.37M $570.60M March 31, 2014
PRIMECAP Management Company 8.16M $556.85M March 31, 2014
Vanguard 8.03M $547.72M March 31, 2014
FMR 7.30M $497.84M March 31, 2014
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
STATE STREET CORPORATION 3.89M $265.56M March 31, 2014
Capital World Investors^ 3.68M $205.21M June 30, 2013
BlackRock Institutional Trust Company, N.A. 3.47M $237.03M March 31, 2014
Wells Fargo & Company 3.47M $260.08M March 31, 2014
Inves 3.19M $128.31M Sept. 30, 2012
Manning & Napier Advisors 3.04M $96.76M Sept. 30, 2011
BNP PARIBAS ARBITRAGE, SNC 2.94M $302.99M March 31, 2014
BlackRock Fund Advisors 2.84M $194.00M March 31, 2014
Cramer Rosenthal McGlynn 2.82M $96.96M Dec. 31, 2011
Columbia Wanger Asset Management 2.70M $150.63M June 30, 2013
T. Rowe Price Associates 2.68M $188.11M Dec. 31, 2013
William Blair $ Company 2.64M $185.46M Dec. 31, 2013
Porter Orlin 2.61M $128.63M Dec. 31, 2012
Altrinsic Global Advisors 2.55M $158.71M March 31, 2013

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Sectoral Asset Management Sept. 30, 2011 3.54M $112.96M
Munder Capital Management Sept. 30, 2011 2.98M $94.96M
OrbiMed Advisors June 30, 2011 2.64M $71.86M